Yu Ozawa

17PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersPhysiotherapyMedical molecular engineering of nucleic acids and proteinsMedical parasitologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 14, 2026
Prognostic Impact and Metastasis Propensity of Grade Group 5 Prostate Cancer Following Permanent Seed Implantation Brachytherapy-Based Trimodality Therapy: Implications for Intensified Staging and Systemic Therapy Optimization.

|Jun 11, 2026
Does Aquablation Therapy Improve Lower Urinary Tract Symptoms in Patients Aged ≥ 75 Years With Benign Prostatic Obstruction?

|Apr 11, 2026
Risk factors for seminal vesicle invasion at radical prostatectomy.

Yu Ozawa, Marcio Covas Moschovas, Carlo Andrea Bravi

|Feb 02, 2026
Optimizing Patient Selection for Aquablation During the Initial Adoption Phase: Prostates Smaller Than 100 mL.

Shin Koike, Yu Ozawa, Kei Ushijima

|Jan 18, 2026
Incremental Predictive Value of the Oncotype Genomic Prostate Score for Adverse Pathology in Active Surveillance Candidates.

Yu Ozawa, Marcio Covas Moschovas, Marco Sandri

|Dec 17, 2025
Cell Cycle Progression Score Identifies Biopsy-Undetected Grade Group 5 Prostate Cancer.

Yu Ozawa, Marcio Covas Moschovas, Marco Sandri

Pageof 3

Frequent Collaborators

3 joint publications

Shady Saikali

3 joint publications

Marco Sandri

3 joint publications

Shin Koike

2 joint publications

Dean Elterman